Crinetics Pharmaceuticals (CRNX) Short Interest Ratio & Short Volume $54.79 -0.58 (-1.05%) (As of 10:09 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Crinetics Pharmaceuticals Short Interest DataCrinetics Pharmaceuticals (CRNX) has a short interest of 6.01 million shares. This marks a -7.54% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.4, indicating that it would take 8.4 days of the average trading volume of 770,110 shares to cover all short positions.Current Short Interest6,010,000 sharesPrevious Short Interest6,500,000 sharesChange Vs. Previous Month-7.54%Dollar Volume Sold Short$343.77 millionShort Interest Ratio8.4 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares92,738,000 sharesPercentage of Shares Shorted6.48%Today's Trading Volume62,611 sharesAverage Trading Volume770,110 sharesToday's Volume Vs. Average8% Short Selling Crinetics Pharmaceuticals? Sign up to receive the latest short interest report for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRNX Short Interest Over TimeCRNX Days to Cover Over TimeCRNX Percentage of Float Shorted Over Time Ad DTIWill the Nasdaq 100 crash?In a world where some top money managers say you should “diversify” with a basket of stocks to help lower risk in your portfolio… And others say you should focus on only one ticker at a time because you can’t really keep detailed tabs on 10, 20 or more stocks at once… My #1 strategy to play the Nasdaq bull run has shown the power to provide the best of BOTH worlds at the same time. Because it harnesses ONE ticker that bottles up all the firepower of Apple, Nvidia, Tesla and more into one place… While I cannot promise future returns or against losses… This strategy targets major payouts OVERNIGHT!Click here to get the details. Crinetics Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20246,010,000 shares $343.77 million -7.5%N/A8.4 $57.20 11/15/20246,500,000 shares $355.68 million -6.3%N/A9.1 $54.72 10/31/20246,940,000 shares $388.36 million +5.3%N/A10.5 $55.96 10/15/20246,590,000 shares $379.58 million -2.8%N/A9.8 $57.60 9/30/20246,780,000 shares $346.46 million +11.0%N/A10.3 $51.10 9/15/20246,110,000 shares $328.72 million -1.8%N/A8.2 $53.80 Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20246,220,000 shares $330.03 million -3.9%N/A8.3 $53.06 8/15/20246,470,000 shares $339.87 million +5.7%N/A8 $52.53 7/31/20246,120,000 shares $325.09 million -7.0%N/A6.6 $53.12 7/15/20246,580,000 shares $356.24 million +12.1%N/A7 $54.14 6/30/20245,870,000 shares $262.92 million +0.2%N/A6.5 $44.79 6/15/20245,860,000 shares $265.63 million +16.5%N/A6.7 $45.33 5/31/20245,030,000 shares $223.38 million +2.4%N/A5.6 $44.41 5/15/20244,910,000 shares $247.91 million No ChangeN/A5.5 $50.49 4/30/20244,910,000 shares $215.16 million -5.9%N/A5.9 $43.82 4/15/20245,220,000 shares $228.01 million +6.3%N/A6.5 $43.68 3/31/20244,910,000 shares $229.84 million -2.0%N/A6.1 $46.81 3/15/20245,010,000 shares $195.04 million +5.7%N/A6.7 $38.93 2/29/20244,740,000 shares $194.06 million +5.1%N/A6 $40.94 2/15/20244,510,000 shares $166.51 million -11.1%N/A5.8 $36.92 1/31/20245,070,000 shares $184.95 million -0.8%N/A6.2 $36.48 1/15/20245,110,000 shares $190.04 million -0.6%N/A6 $37.19 12/31/20235,140,000 shares $182.88 million -13.6%N/A5.9 $35.58 12/15/20235,950,000 shares $205.04 million -6.7%N/A6.4 $34.46 11/30/20236,380,000 shares $202.82 million +2.9%N/A4 $31.79 11/15/20236,200,000 shares $179.06 million -7.6%N/A4 $28.88 10/31/20236,710,000 shares $196.54 million -1.5%N/A4.4 $29.29 10/15/20236,810,000 shares $198.24 million +16.4%N/A4.7 $29.11 9/30/20235,850,000 shares $173.98 million +43.7%N/A4.1 $29.74 9/15/20234,070,000 shares $120.02 million -10.4%N/A3.1 $29.49 8/31/20234,540,000 shares $78.63 million +21.4%N/A5.2 $17.32 8/15/20233,740,000 shares $62.53 million +11.0%N/A7.9 $16.72 7/31/20233,370,000 shares $64.03 million -2.9%N/A7.2 $19.00 7/15/20233,470,000 shares $70.68 million +1.5%N/A7.2 $20.37 6/30/20233,420,000 shares $61.63 million +4.0%N/A7.6 $18.02 6/15/20233,290,000 shares $68.33 million No ChangeN/A7 $20.77 5/31/20233,290,000 shares $71.82 million -4.4%N/A7.2 $21.83 5/15/20233,440,000 shares $76.82 million -18.9%N/A7.7 $22.33 4/30/20234,240,000 shares $82.85 million -1.2%N/A9.9 $19.54 4/15/20234,290,000 shares $68.34 million -6.3%N/A10.6 $15.93Is the Trump/Musk duo good for shares of TSLA? (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. 3/31/20234,580,000 shares $73.55 million +12.3%N/A10.8 $16.06 3/15/20234,080,000 shares $70.14 million +12.1%N/A10.1 $17.19 2/28/20233,640,000 shares $71.49 million +7.4%N/A8.9 $19.64 2/15/20233,390,000 shares $67.70 million -4.0%N/A8.8 $19.97 1/31/20233,530,000 shares $69.22 million -5.4%N/A9.3 $19.61 1/15/20233,730,000 shares $67.29 million No ChangeN/A11.1 $18.04 12/30/20223,730,000 shares $68.26 million +3.3%N/A11.7 $18.30 12/15/20223,610,000 shares $58.63 million -5.3%N/A12.1 $16.24 11/30/20223,810,000 shares $68.08 million -1.3%N/A14.3 $17.87 11/15/20223,860,000 shares $70.41 million -3.7%N/A14.3 $18.24 10/31/20224,010,000 shares $74.02 million -1.7%N/A14.4 $18.46 10/15/20224,080,000 shares $72.05 million +1.5%N/A15 $17.66 9/30/20224,020,000 shares $78.95 million +3.1%N/A15.6 $19.64 9/15/20223,900,000 shares $83.34 million +9.9%N/A14 $21.37 8/31/20223,550,000 shares $67.02 million +13.4%N/A12.3 $18.88 8/15/20223,130,000 shares $70.02 million +12.6%N/A10.3 $22.37 7/31/20222,780,000 shares $53.40 million -2.1%N/A8.9 $19.21 7/15/20222,840,000 shares $58.82 million -1.1%N/A9 $20.71 6/30/20222,870,000 shares $53.53 million +5.9%N/A8.3 $18.65 6/15/20222,710,000 shares $47.86 million +8.8%N/A7.4 $17.66 5/31/20222,490,000 shares $41.71 million +2.1%N/A7.5 $16.75 5/15/20222,440,000 shares $45.75 million +11.9%N/A7.9 $18.75 4/30/20222,180,000 shares $44.30 million -18.1%N/A7.9 $20.32 4/15/20222,660,000 shares $69.16 million +0.8%N/A9.5 $26.00 3/31/20222,640,000 shares $57.95 million +13.3%N/A10.7 $21.95 3/15/20222,330,000 shares $44.46 million +10.4%6.2%9.6 $19.08 2/28/20222,110,000 shares $42.24 million +0.5%5.6%8.1 $20.02 2/15/20222,100,000 shares $41.43 million +23.5%5.6%7.6 $19.73 1/31/20221,700,000 shares $32.11 million +39.3%N/A6.1 $18.89 1/15/20221,220,000 shares $29.29 million -6.9%N/A4.3 $24.01 12/31/20211,310,000 shares $37.22 million +12.0%N/A4.1 $28.41 12/15/20211,170,000 shares $29.45 million +18.1%N/A3.8 $25.17 11/30/2021990,900 shares $27.07 million -1.9%N/A3.6 $27.32 11/15/20211,010,000 shares $27.26 million -13.7%N/A3.8 $26.99 10/29/20211,170,000 shares $29.17 million -17.0%3.4%4.4 $24.93 10/15/20211,410,000 shares $27.48 million -4.7%4.8%5.7 $19.49 9/30/20211,480,000 shares $31.15 million +16.5%5.0%8.5 $21.05 9/15/20211,270,000 shares $29.85 million -3.1%4.3%6.7 $23.50 8/31/20211,310,000 shares $30.88 million +5.7%4.7%6.7 $23.57 8/13/20211,240,000 shares $27.60 million -4.6%4.4%6.3 $22.26 7/30/20211,300,000 shares $23.37 million -0.8%4.9%7.8 $17.98 7/15/20211,310,000 shares $25.82 million -3.7%4.5%8.2 $19.71 6/30/20211,360,000 shares $25.64 million +2.3%4.7%7.9 $18.85 6/15/20211,330,000 shares $24.25 million -8.3%4.6%7.9 $18.23 5/28/20211,450,000 shares $25.45 million -4.6%5.0%10.2 $17.55 5/14/20211,520,000 shares $24.17 million -0.7%N/A12 $15.90 4/30/20211,530,000 shares $27.17 million -0.7%N/A11.1 $17.76 4/15/20211,540,000 shares $25.29 million +2.0%N/A11.1 $16.42 3/31/20211,510,000 shares $23.31 million -2.6%N/A11 $15.44 3/15/20211,550,000 shares $26.24 million +1.3%N/A11.1 $16.93Is the Trump/Musk duo good for shares of TSLA? (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. 2/26/20211,530,000 shares $23.03 million +10.9%N/A11.2 $15.05 2/12/20211,380,000 shares $23.78 million -7.4%N/A9 $17.23 1/29/20211,490,000 shares $22.22 million +2.1%N/A9.5 $14.91 1/15/20211,460,000 shares $21.58 million +1.4%N/A8.3 $14.78 12/31/20201,440,000 shares $19.71 million +9.9%N/A8.2 $13.69 12/15/20201,310,000 shares $17.99 million +0.8%N/A8.1 $13.73 11/30/20201,300,000 shares $18.67 million +3.2%N/A8.8 $14.36 11/15/20201,260,000 shares $16.23 million +7.7%N/A9.1 $12.88 10/30/20201,170,000 shares $14.60 million -14.6%N/A9.9 $12.48 10/15/20201,370,000 shares $22.15 million -3.5%N/A13.2 $16.17 9/30/20201,420,000 shares $22.25 million +2.2%N/A14.3 $15.67 9/15/20201,390,000 shares $22.27 million -3.5%N/A8.7 $16.02 8/31/20201,440,000 shares $23.08 million -0.7%N/A7.6 $16.03 8/14/20201,450,000 shares $22.05 million -2.7%N/A7.1 $15.21 7/31/20201,490,000 shares $20.68 million -15.8%N/A6.8 $13.88 7/15/20201,770,000 shares $26.92 million -30.3%N/A8.1 $15.21 6/30/20202,540,000 shares $45.42 million +84.1%10.6%10.4 $17.88 6/15/20201,380,000 shares $23.54 million No Change5.7%7.2 $17.06 5/29/20201,380,000 shares $22.55 million +3.0%5.8%8.7 $16.34 5/15/20201,340,000 shares $26.40 million -11.3%N/A9.8 $19.70 4/30/20201,510,000 shares $25.82 million -5.0%N/A12.6 $17.10 4/15/20201,590,000 shares $24.61 million +0.6%10.9%14.3 $15.48 3/31/20201,580,000 shares $28.01 million +2.2%11.1%21.7 $17.73 3/13/20201,545,700 shares $21.33 million -0.3%11.0%38.6 $13.80 2/28/20201,550,000 shares $20.94 million -3.7%11.1%24.3 $13.51 2/14/20201,610,000 shares $27.45 million -10.1%11.5%24.8 $17.05 1/31/20201,790,000 shares $38.99 million -2.7%12.8%27.4 $21.78 1/15/20201,840,000 shares $40.96 million No Change13.2%30.4 $22.26 12/31/20191,840,000 shares $41.53 million -9.8%13.2%32.5 $22.57 CRNX Short Interest - Frequently Asked Questions What is Crinetics Pharmaceuticals' current short interest? Short interest is the volume of Crinetics Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 6,010,000 shares of CRNX short. Learn More on Crinetics Pharmaceuticals' current short interest. What is a good short interest ratio for Crinetics Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRNX shares currently have a short interest ratio of 8.0. Learn More on Crinetics Pharmaceuticals's short interest ratio. Is Crinetics Pharmaceuticals' short interest increasing or decreasing? Crinetics Pharmaceuticals saw a decrease in short interest in the month of November. As of November 30th, there was short interest totaling 6,010,000 shares, a decrease of 7.5% from the previous total of 6,500,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Crinetics Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Crinetics Pharmaceuticals: BeiGene, Ltd. (1.37%), Teva Pharmaceutical Industries Limited (1.98%), Moderna, Inc. (11.90%), Viatris Inc. (1.78%), Genmab A/S (0.32%), Summit Therapeutics Inc. (2.28%), Sarepta Therapeutics, Inc. (6.09%), Dr. Reddy's Laboratories Limited (1.32%), Vaxcyte, Inc. (8.85%), Catalent, Inc. (8.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Crinetics Pharmaceuticals stock? Short selling CRNX is an investing strategy that aims to generate trading profit from Crinetics Pharmaceuticals as its price is falling. CRNX shares are trading up $0.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Crinetics Pharmaceuticals? A short squeeze for Crinetics Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRNX, which in turn drives the price of the stock up even further. How often is Crinetics Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRNX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies BeiGene Short Interest Data Teva Pharmaceutical Industries Short Interest Data Moderna Short Interest Data Viatris Short Interest Data Genmab A/S Short Interest Data Summit Therapeutics Short Interest Data Sarepta Therapeutics Short Interest Data Dr. Reddy's Laboratories Short Interest Data Vaxcyte Short Interest Data Catalent Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRNX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
